We caught up with Hervé Affagard, CEO of MaaT Pharma and President of EMIH for an exclusive interview to discuss the far reaching impact of the ARES Phase 3 unprecedented results Read the full interview below. Hervé Affagard talks Phase 3 results, the regulatory...
The event will take place on January 23, 2025, in Lyon This day offers a unique opportunity for microbiota stakeholders (academics, clinicians, and industry leaders) to gather around current, innovation-driven topics. Enjoy a 30% discount to join discussions on the...
Paris – France – September 25 2024, 4:00 pm CET – The European Microbiome Innovation for Health (EMIH) association Microbiome Times Magazine, the microbiome industry’s leading B2B publication, is pleased to announce its collaboration with the...
Paris – France – September 23, 2024, 2:00 pm CET – The European Microbiome Innovation for Health (EMIH) association today announced an agreement between the Microbiome Therapeutics Innovation Group (MTIG) and EMIH for a collaboration to...